Previous Close | 0.1000 |
Open | 0.1000 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.1000 - 0.1000 |
52 Week Range | 0.0688 - 0.1751 |
Volume | |
Avg. Volume | 53 |
Market Cap | 36.632M |
Beta (5Y Monthly) | 1.71 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
FYI Resources Ltd (ASX:FYI) managing director Roland Hill joins Proactive’s Elisha Newell after the company achieved a 15% increase in high purity alumina (HPA) output during its pilot production c...
FYI Resources (ASX:FYI) managing director Roland Hill is back with Proactive after the company kicked off a milestone high purity alumina (HPA) production run at its Perth pilot plant. Hill says th...
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
IRVING, Texas, June 29, 2022--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2023 financial results after market close on Wednesday, August 3, 2022. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
IRVING, Texas & NASHVILLE, Tenn., June 23, 2022--McKesson Corporation (NYSE: MCK) and HCA Healthcare, Inc. (NYSE: HCA) announced today an agreement to form a joint venture combining McKesson’s US Oncology Research (USOR) and HCA Healthcare’s Sarah Cannon Research Institute (SCRI). USOR is the research arm of McKesson’s The US Oncology Network and draws from a network of experienced investigators and dedicated clinical staff who specialize in oncology clinical trials. SCRI, which is the research